Comment Comment by jtrn For semaglutide, the newest and most potent GLP1.United States: The main patent is expected to expire around 2032. Monthly Price: $950 - $1,350+ (cash price without insurance)Norway: The main patent is expected to expire around 2031. Monthly Price: $109 - $301 (cash price equivalent in USD) parent jtrn 1 year ago
United States: The main patent is expected to expire around 2032. Monthly Price: $950 - $1,350+ (cash price without insurance)
Norway: The main patent is expected to expire around 2031. Monthly Price: $109 - $301 (cash price equivalent in USD)